Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome - 04/02/21

Doi : 10.1016/j.jaci.2020.07.024

Rishi R. Goel, MSc ^a,^{^{∗
Rishi R. Goel, MSc, is currently at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.},}^{^{‡
These authors contributed equally to this work.}}, Shuichiro Nakabo, MD, PhD ^a,^{^{‡
These authors contributed equally to this work.}}, Brian L.P. Dizon, MD, PhD ^b,^{^{‡
These authors contributed equally to this work.}}, Amanda Urban, CRNP ^c, Meryl Waldman, MD ^d, Lillian Howard, NP ^d, Dirk Darnell, MA, RN ^c, Munir Buhaya, BS ^c, Carmelo Carmona-Rivera, PhD ^a, Sarfaraz Hasni, MD ^a, Mariana J. Kaplan, MD ^a, Alexandra F. Freeman, MD ^c,^{^{§
These authors contributed equally to this work.}} , Sarthak Gupta, MD ^a,^{^{§
These authors contributed equally to this work.}}
^a Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md
^b Rheumatology Training Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md
^c Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md
^d Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md

Supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the US Government.

Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.

Esportazione

Vol 147 - N° 2

P. 746 - Febbraio 2021 Ritorno al numero

Articolo precedente

ITK deficiency presenting as autoimmune lymphoproliferative syndrome
Jacqueline G. Wallace, Mohammed F. Alosaimi, Claudia Djambas Khayat, Faris Jaber, Abduarahman Almutairi, Sarah Beaussant-Cohen, Geraldine Pinkus, Mark Fleming, Cybel Mehawej, Janet Chou, Raif S. Geha

| Articolo seguente

Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency
Leslie Naesens, Julie Smet, Simon J. Tavernier, Petra Schelstraete, Levi Hoste, Stijn Lambrecht, Helene Verhelst, Jutte van der Werff ten Bosch, Alina Ferster, Sophie Blumental, Pascale Hilbert, Tessa Kerre, Johan Vande Walle, Christoph Licht, Lubka T. Roumenina, Patrick Stordeur, Filomeen Haerynck

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome - 04/02/21

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL